This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Washington University. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Innovations by Adam Rosenberg
Introduction
Adam Rosenberg is an accomplished inventor based in Nashville, Missouri. He has made significant contributions to the field of biomedical research, particularly in the area of sphingosine-1-phosphate receptor 1 (S1P1). His work focuses on the development of compositions and methods that have the potential to impact the treatment of various diseases associated with S1P1.
Latest Patents
Adam Rosenberg holds a patent for "Compositions for binding sphingosine-1-phosphate receptor 1 (S1P1), imaging of S1P1, and methods of use thereof." This patent encompasses various aspects, including the provision of compositions for binding S1P1, imaging agents for S1P1, and therapeutic methods for treating S1P1 associated diseases, disorders, and conditions. His innovative approach aims to enhance the imaging of S1P1 and provide new therapeutic options for related health issues. He has 1 patent to his name.
Career Highlights
Adam is affiliated with Washington University, where he continues to advance his research and contribute to the scientific community. His work is characterized by a commitment to exploring new frontiers in biomedical science, particularly in the context of receptor-targeted therapies.
Collaborations
Adam has collaborated with notable colleagues, including Junbin Han and Zhude Tu. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in their field.
Conclusion
In summary, Adam Rosenberg is a notable inventor whose work on S1P1 has the potential to influence the treatment of various diseases. His contributions to the field of biomedical research are significant and reflect a dedication to innovation and collaboration.